Patents Examined by Thalan N. Ton
  • Rodent HER2 tumor model
    Patent number: 6632979
    Abstract: The invention concerns HER2-transgenic non-human mammals, animal models for screening drug candidates for the treatment of diseases and disorders associated with the overexpression of HER2. In particular, the invention concerns animal models designed to test drug candidates for the treatment of HER2-overexpressing cancers, including breast cancer, that are not responding or poorly responding to current treatments.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: October 14, 2003
    Assignee: Genentech, Inc.
    Inventors: Sharon Erickson, Kathleen King, Ralph Schwall